Dialysis fistula creation is a commonly performed procedure for patients with end-stage renal disease (ESRD) who require permanent vascular access in order to receive long term hemodialysis. The ideal dialysis fistula delivers a high flow rate sufficient for effective dialysis, is suitable for repeated cannulation, and has long term patency rates with minimal complications. According to the National Kidney Foundation, over 400,000 patients are treated with hemodialysis in the United States with Medicare spending, on average, $90,000 per patient per year of treatment.
While there are various techniques for permanent dialysis access, arteriovenous fistulas (AVFs) are proven to have superior clinical and economic advantages. Guidelines from the National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative (KDOQI) and the Fistula First Initiative recommend that autogenous AVFs should be considered as the preferred initial access for hemodialysis in patients with ESRD, followed by prosthetic grafts, and finally hemodialysis catheters.
Studies have demonstrated a clinically significant decrease in the rate of infections, hospitalizations, catheter failure, central venous stenosis, and mortality, as well as overall cost with AVFs compared to prosthetic grafts or hemodialysis catheters. Despite the prolonged maturation time that delays immediate use, patency rates for AVFs range from 3 to 5 years, compared to 1 to 2 years for AV grafts.
This article will discuss the relevant anatomy, indications, contraindications, procedure details, and complications associated with arteriovenous dialysis fistula creation.
An arteriovenous fistula is a surgical connection between an artery and a vein. Fistula maturation is a dynamic process called venous arterialization in which structural and functional remodeling of the venous wall is facilitated by the release of nitrous oxide and the breakdown of elastin to permit enlargement of the outflow vein. Clinically mature arteriovenous fistulas are easier to cannulate with repetitive needlesticks and provide high flow rates necessary to sustain hemodialysis.
The KDOQI’s “Rule of 6’s” is used to assess fistula maturation and states that 6 weeks after creation, an arteriovenous fistula should achieve a blood flow rate of at least 600 ml/min, a diameter of at least 6 mm, an access length of 6 cm for cannulation, and a depth of 6 mm or less from the skin surface.
A thorough understanding of the upper extremity vascular anatomy is paramount to successful AVF creation.
According to the KDOQI Clinical Practice Guidelines, patients should receive education about kidney failure if they reach chronic kidney disease stage 4 (a glomerular filtration rate (GFR) of less than 30 ml/min) or have an imminent need for maintenance dialysis at the time of initial assessment. This includes a discussion about the options for treatment, such as kidney transplantation, peritoneal dialysis, hemodialysis, or conservative treatment.
Patients with chronic kidney disease stage 5 (GFR 10 to 15 ml/min) require maintenance dialysis in order to regulate metabolic derangements such as hyperkalemia, metabolic acidosis, hypervolemia, and uremic symptoms. The nephrologist plays a key role in determining the type of dialysis best suited for their patients. If hemodialysis is chosen, patients are referred to a vascular surgeon to determine if arteriovenous fistula creation is feasible.
Absolute contraindications to dialysis fistula creation include venous occlusion, amputation, or advanced peripheral artery disease with necrosis on the side of AV fistula creation.
Relative contraindications include pacemaker placement, central venous stenosis, active infection, or prior axillary node dissection. Patients who are elderly, have advanced heart failure, or decreased life expectancy are considered high risk.
A standard vascular operative tray is essential to the surgeon’s success in performing this procedure. Surgical instruments required include scalpels, needle holders, tissue forceps, scissors, self-retaining retractors, vessel loops, bulldog clamps, and vascular clamps of the surgeon’s preference. A vascular anastomosis is typically performed using monofilament nonabsorbable suture. Suction and electrocautery are also essential. A Doppler ultrasound should be available throughout the procedure to assess patency and flow.
In order to perform a dialysis fistula creation, the surgeon should have adequate experience in vascular surgery, often fellowship training. Essential personnel are the standard surgical team members including the operating surgeon, first assistant, anesthesiologist, scrub technician, and a circulating nurse.
The planning for dialysis fistula creation requires proper patient selection, starting with a thorough history and physical examination. Pertinent medical and surgical history includes the presence of an automatic implantable cardioverter-defibrillator (AICD) or pacemaker, prior mastectomy or axillary dissection, or previous central venous catheters that may compromise venous drainage. Physical examination should include inspection of the venous system, blood pressure measurements, assessment of pulse symmetry, and performing an Allen test to evaluate patency of the palmar arch.
The patient’s vascular anatomy is the key determinant in whether an AV fistula can be created successfully and maintain long term patency. Preoperative vein mapping using duplex ultrasound is used to assess the structural and functional aspects of the vessels. The KDOQI guidelines suggest having a vein diameter of 2.0 mm to 2.5 mm, an access segment of 6 cm for cannulation, and patent central and draining veins for successful AVF creation. The Society of Vascular Surgery recommends placing access as distal in the upper extremity as possible to preserve future central access while giving preference to the non-dominant arm.
Dialysis fistula creation of choice is radiocephalic fistula, brachiocephalic fistula, transposed brachiobasilic fistula, and then loop arteriovenous graft. While autogenous AV fistulas are the gold standard for hemodialysis patients, patients who are elderly (small-caliber vessels), have poor vasculature (presence of calcification or patients with diabetes), have slowly progressive chronic kidney disease or those with poor health and limited life expectancy are unlikely to benefit from AV fistula creation.
Overall, in addition to vascular anatomy, a patient-centered approach must be taken, including patient preferences, attributes, life expectancy, and quality of life when considering vascular dialysis access.
There are several arteriovenous fistula creation sites that can be made depending on the patient’s vascular anatomy. The patient should be positioned in a supine position with the corresponding arm outstretched to 90 degrees, prepped and draped in usual sterile fashion. Principles of arteriovenous fistula creation include obtaining vessel control proximally and distally, and the anastomosis should be made without tension or kinking.
Radiocephalic Fistula (Brescia-Cimino)
The radiocephalic fistula is a distal forearm fistula created by anastomosing the cephalic vein to the radial artery. A transverse incision is made in the wrist. The radial artery and cephalic vein are dissected, mobilized, and secured using vessel loops. Any small tributaries can be ligated and divided. An anterolateral arteriotomy is made, and the artery is flushed with heparinized saline. An end-to-side anastomosis can be made by ligating and dividing the distal cephalic vein and spatulating the end to match the size of the arteriotomy. A side-to-side anastomosis can be made by creating a venotomy in the corresponding portion of the cephalic vein. The arteriovenous anastomosis is then performed using a running nonabsorbable monofilament suture. Vascular doppler should be used to confirm thrill through the fistula, as well as the distal radial artery signal. Hemostasis is achieved, subcutaneous tissues are approximated, and skin is closed using nonabsorbable suture.
Brachiocephalic Fistula (Kaufmann)
The brachiocephalic fistula is an upper arm fistula created by anastomosing the cephalic vein to the brachial artery. A transverse incision is made over the antecubital fossa. The brachial artery and cephalic vein are dissected, mobilized, and secured using vessel loops. Any small tributaries can be ligated and divided. An arteriotomy is made, and the artery is flushed with heparinized saline. An end-to-side anastomosis is performed by ligating and dividing the distal cephalic vein and spatulating the end to match the size of the arteriotomy. The arteriovenous anastomosis is then performed using a running nonabsorbable monofilament suture. Vascular doppler should be used to confirm thrill through the fistula, as well as the distal radial artery signal. Hemostasis is achieved, subcutaneous tissues are approximated, and skin is closed using nonabsorbable suture.
Transposition Brachiobasilic Fistula (One Stage vs Two Stage)
The brachiobasilic fistula is used when the techniques above are not feasible or have failed. The basilic vein is medial and deep; therefore, in order to be easily accessed, the vein must be transposed into a more superficial and lateral location. This can be done in one or two stages. The two-stage approach has a better maturation and patency rate but requires reintervention and additional time before use.
One Stage: A longitudinal incision is made in the upper arm over the previously mapped basilic vein from the axilla to the antecubital fossa. The incision is deepened, and the brachial fascia is incised to expose the basilic vein. The brachial artery and basilic vein are dissected, mobilized, and secured using vessel loops. Care is taken to avoid injury to the median antebrachial cutaneous nerve. An arteriotomy is made in the proximal brachial artery and then flushed with heparinized saline. A curved tunneler is used to create a subcutaneous tunnel along the anterior aspect of the upper arm. The distal basilic vein is ligated and divided and then tunneled laterally and superficially in a curved fashion. The end of the basilic vein is spatulated to match the size of the arteriotomy, and an end-to-side anastomosis is performed using a running nonabsorbable monofilament suture. Vascular doppler should be used to confirm thrill through the fistula, as well as the distal radial artery signal. Hemostasis is achieved, subcutaneous tissues are approximated, and skin is closed using nonabsorbable suture.
Two Stage: The first stage starts with making a transverse incision just distal to the antecubital fossa. The brachial artery and basilic vein are dissected, mobilized, and secured using vessel loops. An arteriotomy is made in the distal brachial artery and then flushed with heparinized saline. The distal basilic vein is ligated and divided, and the end spatulated to match the arteriotomy. An end-to-side anastomosis is made using a running nonabsorbable monofilament suture. The fistula is then allowed to mature over the next 6-8 weeks. The patient is then brought back to the operating room for the second stage. A longitudinal incision is made in the upper arm from the axilla to the antecubital fossa. The arterialized basilic vein is dissected proximally in a similar fashion and transected proximal to the anastomosis. The vein is mobilized and tunneled laterally and superficially using a curved tunneler. A new proximal brachiobasilic end-to-end anastomosis is made using nonabsorbable monofilament suture.
As with any surgical procedure, there is a risk of bleeding, infection, or damage to surrounding structures. High-risk patients may be at increased risk for complications that may result in significant morbidity. Complications can be divided into immediate, early (days to months), or late (after maturity).
The most common dialysis fistula complications that may require intervention include aneurysm, infection, thrombosis, central venous stenosis, ischemic steal syndrome, and failure to mature.
Hemodialysis is a standard therapeutic option for patients with ESRD. Arteriovenous fistula creation is associated with longer maturation time but decreased risk of infection, hospitalizations, central venous stenosis, and mortality when compared to prosthetic grafts or dialysis catheters.
An interprofessional team approach is crucial to the success of ESRD patients and should involve collaboration between primary care physicians, nephrologists, vascular access surgeons, interventionalists, dialysis nurses, and vascular access coordinators.
The primary care physician must actively screen patients for chronic kidney disease and intervene with timely referral to a nephrologist for evaluation and treatment. The nephrologist oversees the care of the patient to ensure appropriate dialysis care. Vascular surgeons must decide the placement and type of vascular access that will yield the greatest success rate. Given the high rate of vascular access dysfunction, interventionalists can play a critical role in the maintenance and restoration of dialysis access using endovascular techniques. The dialysis nurse plays a critical role in patient care as they can examine and monitor access three times per week during dialysis. Lastly, the vascular access coordinator is essential for organizing patient hemodialysis care.
Communication and coordination between the interprofessional team are required to optimize vascular access outcomes as well as patient morbidity and mortality.
Nursing staff must communicate effectively during handoff to report a history of end-stage renal disease and arteriovenous dialysis fistula. Nurses can help preserve veins for dialysis fistula creation by avoiding peripheral venous access, blood draws, or blood pressure measurements on the side of fistula planning. For nurses taking care of patients on the floor, it is paramount to learn how to assess for fistula thrill, differentiate thrill from pulsating fistulas, and identify loss of thrill. Understanding complications such as ischemic steal syndrome and patients complaining of numbness or tingling after dialysis can prompt nurses to call surgical services sooner.
Dialysis nurses also play a critical role in evaluating and managing dialysis fistulas. Dialysis nurses can report arteriovenous fistula malfunction during dialysis, such as decreased flow rates (possible inflow or outflow obstruction), delayed hemostasis at needle puncture sites (possible outflow obstruction), or erythema and drainage overlying the fistula site (possible infection). Dialysis nurses can also convey difficult access due to fistula depth so that patients can undergo a procedure called superficialization if necessary.
Doppler Signal: Place the doppler probe over the fistula to obtain a signal. Doppler signals may be described as monophasic, biphasic or triphasic.
Thrill: Place the tips of the fingers lightly over the fistula. A thrill is a vibration felt over the fistula and implies patency.
Pulsation: Place the tips of the fingers lightly over the fistula. Pulsation is a strong heartbeat felt over the fistula, which may indicate possible outflow stenosis.
Overlying Skin Changes: Erythema, warmth, edema, or drainage may all be signs of possible fistula infection and can lead to loss of vascular access. These findings should be promptly reported to a physician.
Bleeding: Continuous oozing at the cannulation site may suggest outflow stenosis or may be the result of coagulopathy secondary to uremia.
|||MacRae JM,Oliver M,Clark E,Dipchand C,Hiremath S,Kappel J,Kiaii M,Lok C,Luscombe R,Miller LM,Moist L, Arteriovenous Vascular Access Selection and Evaluation. Canadian journal of kidney health and disease. 2016; [PubMed PMID: 28270917]|
|||KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2015 Nov; [PubMed PMID: 26498416]|
|||Stolic R, Most important chronic complications of arteriovenous fistulas for hemodialysis. Medical principles and practice : international journal of the Kuwait University, Health Science Centre. 2013; [PubMed PMID: 23128647]|
|||Arhuidese IJ,Orandi BJ,Nejim B,Malas M, Utilization, patency, and complications associated with vascular access for hemodialysis in the United States. Journal of vascular surgery. 2018 Oct; [PubMed PMID: 30244924]|
|||Almasri J,Alsawas M,Mainou M,Mustafa RA,Wang Z,Woo K,Cull DL,Murad MH, Outcomes of vascular access for hemodialysis: A systematic review and meta-analysis. Journal of vascular surgery. 2016 Jul; [PubMed PMID: 27345510]|
|||Lee T, Fistula First Initiative: Historical Impact on Vascular Access Practice Patterns and Influence on Future Vascular Access Care. Cardiovascular engineering and technology. 2017 Sep; [PubMed PMID: 28695442]|
|||Oliver MJ, The Science of Fistula Maturation. Journal of the American Society of Nephrology : JASN. 2018 Nov; [PubMed PMID: 30305311]|
|||McIntyre CW,Burton JO, Dialysis. BMJ (Clinical research ed.). 2014 Jan 2; [PubMed PMID: 24384463]|
|||Al-Jaishi AA,Liu AR,Lok CE,Zhang JC,Moist LM, Complications of the Arteriovenous Fistula: A Systematic Review. Journal of the American Society of Nephrology : JASN. 2017 Jun; [PubMed PMID: 28031406]|
|||Marques MG,Ponce P, Pre-operative Assessment for Arteriovenous Fistula Placement for Dialysis. Seminars in dialysis. 2017 Jan; [PubMed PMID: 27866375]|
|||Martin C 3rd,Pillai R, Dialysis Access Anatomy and Interventions: A Primer. Seminars in interventional radiology. 2016 Mar; [PubMed PMID: 27011428]|
|||Kakkos SK,Haddad GK,Weaver MR,Haddad RK,Scully MM, Basilic vein transposition: what is the optimal technique? European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery. 2010 May; [PubMed PMID: 20172751]|